Entegris Investing Cash Flow increased by 42.1% to -$38.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 64.5%, from -$108.30M to -$38.40M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows relatively stable performance with a 0.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$44.00M | -$44.56M | -$166.30M | -$83.28M | -$107.69M | -$4.60B | -$153.07M | -$357.00K | $54.22M | -$76.59M | $575.83M | $181.00M | -$107.90M | -$108.30M | -$66.60M | -$59.60M | -$66.30M | -$38.40M |
| QoQ Change | — | -1.3% | -273.2% | +49.9% | -29.3% | <-999% | +96.7% | +99.8% | >999% | -241.3% | +851.9% | -68.6% | -159.6% | -0.4% | +38.5% | +10.5% | -11.2% | +42.1% |
| YoY Change | — | — | — | — | -144.7% | <-999% | +8.0% | +99.6% | +150.3% | +98.3% | +476.2% | >999% | -118.7% | -159.8% | — | — | +38.6% | +64.5% |